Assembly Bill A4909A

2023-2024 Legislative Session

Provides public access to epinephrine auto-injector devices at schools

download bill text pdf

Sponsored By

Current Bill Status - In Assembly Committee

  • Introduced
    • In Committee Assembly
    • In Committee Senate
    • On Floor Calendar Assembly
    • On Floor Calendar Senate
    • Passed Assembly
    • Passed Senate
  • Delivered to Governor
  • Signed By Governor

Do you support this bill?

Please enter your contact information

Home address is used to determine the senate district in which you reside. Your support or opposition to this bill is then shared immediately with the senator who represents you.

Optional services from the NY State Senate:

Create an account. An account allows you to officially support or oppose key legislation, sign petitions with a single click, and follow issues, committees, and bills that matter to you. When you create an account, you agree to this platform's terms of participation.

Include a custom message for your Senator? (Optional)

Enter a message to your senator. Many New Yorkers use this to share the reasoning behind their support or opposition to the bill. Others might share a personal anecdote about how the bill would affect them or people they care about.
Actions

Bill Amendments

co-Sponsors

2023-A4909 - Details

See Senate Version of this Bill:
S8482
Current Committee:
Assembly Education
Law Section:
Education Law
Laws Affected:
Amd §921-a, Ed L; amd §3000-c, Pub Health L

2023-A4909 - Summary

Provides public access to epinephrine auto-injector devices at schools; establishes public access epinephrine auto-injector device providers.

2023-A4909 - Bill Text download pdf 

                             
                     S T A T E   O F   N E W   Y O R K
 ________________________________________________________________________
 
                                   4909
 
                        2023-2024 Regular Sessions
 
                           I N  A S S E M B L Y
 
                             February 24, 2023
                                ___________
 
 Introduced by M. of A. SAYEGH -- read once and referred to the Committee
   on Education
 
 AN ACT to amend the education law and the public health law, in relation
   to  providing  public  access  to epinephrine auto-injector devices at
   schools
 
   THE PEOPLE OF THE STATE OF NEW YORK, REPRESENTED IN SENATE AND  ASSEM-
 BLY, DO ENACT AS FOLLOWS:
 
   Section  1.  Section 921-a of the education law is amended by adding a
 new subdivision 3 to read as follows:
   3. SCHOOL DISTRICTS, BOARDS OF COOPERATIVE EDUCATIONAL SERVICES, COUN-
 TY VOCATIONAL EDUCATION AND EXTENSION BOARDS, CHARTER SCHOOLS, AND  NON-
 PUBLIC  ELEMENTARY  AND  SECONDARY SCHOOLS IN THIS STATE SHALL BE DEEMED
 "PUBLIC ACCESS EPINEPHRINE AUTO-INJECTOR DEVICE PROVIDERS" AS DEFINED IN
 PARAGRAPH (D) OF SUBDIVISION ONE OF  SECTION  THREE  THOUSAND-C  OF  THE
 PUBLIC  HEALTH  LAW AND SHALL BE SUBJECT TO THE REQUIREMENTS AND LIMITA-
 TIONS OF SUCH SECTION.
   § 2. Subdivision 1 of section 3000-c  of  the  public  health  law  is
 amended by adding a new paragraph (d) to read as follows:
   (D)  "PUBLIC ACCESS EPINEPHRINE AUTO-INJECTOR DEVICE PROVIDER" MEANS A
 PERSON, FIRM, ORGANIZATION OR OTHER ENTITY POSSESSING  OR  OPERATING  AN
 EPINEPHRINE AUTO-INJECTOR DEVICE PURSUANT TO THIS SECTION.
   §  3.  Subdivision  2  of  section  3000-c of the public health law is
 amended by adding a new paragraph (g) to read as follows:
   (G) A PUBLIC ACCESS EPINEPHRINE AUTO-INJECTOR DEVICE PROVIDER SHALL:
   (I) CAUSE AN EPINEPHRINE AUTO-INJECTOR DEVICE  TO  BE  MAINTAINED  AND
 TESTED  ACCORDING  TO  APPLICABLE  STANDARDS OF THE MANUFACTURER AND ANY
 APPROPRIATE GOVERNMENT AGENCY.
   (II) NOTIFY THE REGIONAL COUNCIL OF THE EXISTENCE, LOCATION  AND  TYPE
 OF ANY EPINEPHRINE AUTO-INJECTOR DEVICE IT POSSESSES.
   (III)  POST  A  SIGN OR NOTICE AT THE MAIN ENTRANCE TO THE FACILITY OR
 BUILDING IN WHICH THE EPINEPHRINE AUTO-INJECTOR DEVICE IS STORED,  INDI-
 
  EXPLANATION--Matter in ITALICS (underscored) is new; matter in brackets
                       [ ] is old law to be omitted.
                                                            LBD08722-01-3

co-Sponsors

2023-A4909A (ACTIVE) - Details

See Senate Version of this Bill:
S8482
Current Committee:
Assembly Education
Law Section:
Education Law
Laws Affected:
Amd §921-a, Ed L; amd §3000-c, Pub Health L

2023-A4909A (ACTIVE) - Summary

Provides public access to epinephrine auto-injector devices at schools; establishes public access epinephrine auto-injector device providers.

2023-A4909A (ACTIVE) - Bill Text download pdf 

                             
                     S T A T E   O F   N E W   Y O R K
 ________________________________________________________________________
 
                                  4909--A
 
                        2023-2024 Regular Sessions
 
                           I N  A S S E M B L Y
 
                             February 24, 2023
                                ___________
 
 Introduced  by  M.  of  A.  SAYEGH,  BURDICK,  BENDETT  -- read once and
   referred to the Committee on Education -- recommitted to the Committee
   on Education in accordance with Assembly Rule 3, sec. 2  --  committee
   discharged, bill amended, ordered reprinted as amended and recommitted
   to said committee

 AN ACT to amend the education law and the public health law, in relation
   to  providing  public  access  to epinephrine auto-injector devices at
   schools
 
   THE PEOPLE OF THE STATE OF NEW YORK, REPRESENTED IN SENATE AND  ASSEM-
 BLY, DO ENACT AS FOLLOWS:
 
   Section  1.  Section 921-a of the education law is amended by adding a
 new subdivision 4 to read as follows:
   4. SCHOOL DISTRICTS, BOARDS OF COOPERATIVE EDUCATIONAL SERVICES, COUN-
 TY VOCATIONAL EDUCATION AND EXTENSION BOARDS, CHARTER SCHOOLS, AND  NON-
 PUBLIC  ELEMENTARY  AND  SECONDARY SCHOOLS IN THIS STATE SHALL BE DEEMED
 "PUBLIC ACCESS EPINEPHRINE AUTO-INJECTOR DEVICE PROVIDERS" AS DEFINED IN
 PARAGRAPH (D) OF SUBDIVISION ONE OF  SECTION  THREE  THOUSAND-C  OF  THE
 PUBLIC  HEALTH  LAW AND SHALL BE SUBJECT TO THE REQUIREMENTS AND LIMITA-
 TIONS OF SUCH SECTION.
   § 2. Subdivision 1 of section 3000-c  of  the  public  health  law  is
 amended by adding a new paragraph (d) to read as follows:
   (D)  "PUBLIC ACCESS EPINEPHRINE AUTO-INJECTOR DEVICE PROVIDER" MEANS A
 PERSON, FIRM, ORGANIZATION OR OTHER ENTITY POSSESSING  OR  OPERATING  AN
 EPINEPHRINE AUTO-INJECTOR DEVICE PURSUANT TO THIS SECTION.
   §  3.  Subdivision  2  of  section  3000-c of the public health law is
 amended by adding a new paragraph (g) to read as follows:
   (G) A PUBLIC ACCESS EPINEPHRINE AUTO-INJECTOR DEVICE PROVIDER SHALL:
   (I) CAUSE AN EPINEPHRINE AUTO-INJECTOR DEVICE  TO  BE  MAINTAINED  AND
 TESTED  ACCORDING  TO  APPLICABLE  STANDARDS OF THE MANUFACTURER AND ANY
 APPROPRIATE GOVERNMENT AGENCY.
 
  EXPLANATION--Matter in ITALICS (underscored) is new; matter in brackets
                       [ ] is old law to be omitted.
                                                            LBD08722-03-4
 A. 4909--A                          2

Comments

Open Legislation is a forum for New York State legislation. All comments are subject to review and community moderation is encouraged.

Comments deemed off-topic, commercial, campaign-related, self-promotional; or that contain profanity, hate or toxic speech; or that link to sites outside of the nysenate.gov domain are not permitted, and will not be published. Attempts to intimidate and silence contributors or deliberately deceive the public, including excessive or extraneous posting/posts, or coordinated activity, are prohibited and may result in the temporary or permanent banning of the user. Comment moderation is generally performed Monday through Friday. By contributing or voting you agree to the Terms of Participation and verify you are over 13.

Create an account. An account allows you to sign petitions with a single click, officially support or oppose key legislation, and follow issues, committees, and bills that matter to you. When you create an account, you agree to this platform's terms of participation.